Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040564

SVP, CFO sold 8,186 shares at an average $1.65 ($13,527)

From the SEC's structured data for this filing

Trades in this filing

Hyllengren Eric J · SVP, CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Sale : show line 1 in the form −6,408 $1.65 $10,586 219,734 D
2023-08-16 Sale : show line 2 in the form −1,778 $1.65 $2,941 217,956 D
Open-market sales · 8,186 sh · avg $1.65 · $13,527
Loading xslF345X05/form4.xml…